Key facts
- Notable investors include Radar Ventures (Australia), UNSW Founders.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Herikîn
- ·The full record, as it builds
Funding rounds
No funding rounds for Herikîn are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Herikîn
Developer of RNA manufacturing technology designed to automate and scale mRNA production processes. The company's platform offers modular hardware systems, continuous-flow fluidics and integrated biological processing, enabling pharmaceutical developers, researchers and agricultural producers to produce RNA efficiently for therapeutics, research and crop applications.
- Sector
- Healthcare
- HQ
- Australia
- Website
- herikin.com/
- Ownership
- Privately Held (backing)
Herikîn doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Herikîn shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Herikîn in its N-PORT filings yet. We sweep new filings monthly.